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Glycosylation of cyclooxygenase-2 (COX-2)
influences the migratory potential of COS-1 cells
Julia Hand, Renee Dominguez, Miguel Regidor and Mary B. Sevigny
Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA 94901
ABSTRACT
A cancer cell’s most threatening property is its
ability to metastasize or detach from the primary tumor
and migrate to other locations in the body. Previous
studies have shown that overexpression of the enzyme
cyclooxygenase-2 (COX-2) can increase the metastatic
potential of several cell types. COX-2 is the rate-limiting
enzyme in the prostanoid biosynthesis pathway,
converting arachidonic acid to prostaglandin H2, an
important signaling molecule in the body. Glycosylation
of COX-2 at the amino acid site Asn580 occurs about 50%
of the time, and this results in two forms of the enzyme
with molecular weights 72 and 74kDa. The purpose of
this study was to investigate the impact of glycosylation
of COX-2 at the Asn580 site on the metastatic potential of
cells. COS-1 cells were first transfected with either an
Asn580-mutant human COX-2 gene or the wild-type
human COX-2 gene. A cell migration assay was then
carried out on these two groups of cells. Briefly, 5x104
cells were plated onto the membrane of a Boyden
Chamber, and cells were incubated for 12 hours. Cells
that migrated to the underside of the membrane were
fixed, stained, visualized via light microscopy, and
counted. Our results revealed that cells transfected with
the Asn580-mutant gene migrated faster through the
membrane. This indicates that a lack of glycosylation at
the Asn580 site of the COX-2 enzyme may lead to an
enhanced metastatic potential in cells. Future studies
will analyze the effect of variable COX-2 glycoform
expression on the migratory potential of tumor cell lines
such as MCF-7 and T-47D.

INTRODUCTION
The COX-2 enzyme is found in most vertebrate
tissues. COX-2 catalyzes the synthesis of prostaglandin
H2 (PGH2) from the omega-6 fatty acid arachidonic acid.
PGH2 is then quickly converted into other
prostaglandins
by
downstream
prostaglandin
synthases. These various prostaglandin isomers are
capable of initiating inflammation, fever, pain sensation,
and vasodilation and also play roles in maintenance of
renal function, bone metabolism, and pregnancy.
Known primarily for its role in inflammatory responses,
overexpression of COX-2 has also been found to have a
role in Alzheimer’s disease, rheumatoid arthritis, and
many cancers such as colorectal and breast cancer .
The COX-2 protein is located in the membrane of the
endoplasmic reticulum and the nuclear envelope. The
enzyme has five potential N-linked glycosylation sites–
Asn53, Asn130, and Asn396 are always glycosylated, Asn592
is never glycosylated, and Asn580 is glycosylated 50% of
the time. This latter variable glycosylation site produces
two glycoforms of 72 and 74 kDa.
Our lab has
previously shown that this additional glycosylation
plays a role in the turnover of the COX-2 enzyme and
negatively affects the efficacy of various COX-2
inhibitors.

Since other researchers have shown that
overexpression of COX-2 in cells leads to a more
enhanced metastatic phenotype, our lab is interested in
determining if the glycosylation of COX-2 affects this as
well. Therefore, the purpose of this study is to find out if
the metastatic potential of COX-2-expressing cells
depends upon which glycoform(s) is(are) expressed.
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METHODS
Transfection of COS-1 cells with the COX-2 gene
The transfection of COS-1 cells with either the wild-type
human COX-2 gene or the Asn580-mutant human COX-2
gene was carried out in 5% FBS/DMEM using TransItLT1 transfection reagent from Mirus Bio. Control COS-1
cells were transfected with an empty pcDNA3.1 plasmid
from Invitrogen. Transfection efficiency was confirmed
by co-transfection with pEGFP-1 followed by
fluorescent microscopy detection. Expression of the
COX-2 glycoforms was verified via Western blots.

Sample membranes from a COS-1 cell migration assay. A) Control COS-1 cells
transfected with empty pcDNA3.1 plasmid. B) COS-1 cells expressing the 72/74 kDa COX-2
glycoforms. C) COS-1 cells expressing the 70/72 kDa COX-2 glycoforms. Red circles show
cells that are migrating through the membrane of the Boyden chamber. The cell fills the
entirety of the pore with a strong, purple color. Images of the Boyden chamber membranes
were taken at 200x magnification under a light microscope using Motic software.

Figure 3

Observation of COS-1 cell migration
Transfected cells at a cell density of 5 x 104 cells per
well were plated into Boyden chambers with 8 µm pore
size and incubated at 37C, 5% CO2. After 12 hours of
incubation, cells were fixed in 10% phosphate buffered
formalin for at least 15 minutes. Crystal violet was used
to stain each chamber for 10 minutes, and then the
chambers were placed in distilled H2O to rinse off any
excess crystal violet. Cotton swabs were used to gently
clean the insides of the Boyden chambers, and the
chambers were allowed to air dry for 1 hour to remove
any excess water. After drying, the membranes were
viewed under a light microscope using the computer
program MOTIC to view and capture the images as jpg
files. The pictures were used to count how many cells
migrated across the membranes.

RESULTS
Figure 1

Effect of glycosylation of COX-2 at Asn580 on the migratory ability of COS-1 cells.
Control, COS-1 cells transfected with empty plasmid; 72/74 kDa, COS-1 cells expressing
the 72 and 74 kDa COX-2 glycoforms; 70/72 kDa, COS-1 cells expressing the 70 and 72
kDa COX-2 glycoforms. Results are averages ±SEM; n = 3 independent experiments.

CONCLUSION
The COS-1 cells expressing the 70/72 kDa COX-2 glycoforms had
a greater tendency to migrate across the membrane, indicating
that the lack of glycosylation of COX-2 at Asn580 enhances the
migratory potential of COS-1 cells.

FUTURE STUDIES
Western blot data showing expression of the COX-2 glycoforms.
C = control, COS-1 cells transfected with empty plasmid; WT = COS1 cells transfected with the wild-type COX-2 gene; MUT = COS-1
cells transfected with the mutant gene. Cells transfected with the
wild-type gene expressed the 72 and 74 kDa glycoforms whereas
cells transfected with the Asn580-mutant gene expressed the 72 and
a “new” 70 kDa glycoform.

• Observe the effect of variable COX-2 glycoform expression on the
migratory potential of tumor cell lines such as MCF-7 and T-47D.
• Use 2D gel electrophoresis to observe any differences in protein
expression between the 70/72kDa and 72/74kDa COX-2-expressing cells.
• Determine if this glycosylation affects the invasive potential of cells.

